Skip navigation
Universidade Federal da Bahia |
Repositório Institucional da UFBA
Use este identificador para citar ou linkar para este item: https://repositorio.ufba.br/handle/ri/41286
Registro completo de metadados
Campo DCValorIdioma
dc.creatorBrandão, Najara Amaral-
dc.date.accessioned2025-02-19T16:11:36Z-
dc.date.available2025-02-19T16:11:36Z-
dc.date.issued2024-12-19-
dc.identifier.citationBRANDÃO, Najara Amaral. Influência de polimorfismos em genes relacionados à inflamação na resposta à intervenção dietoterápica sem lactose em pacientes com síndrome metabólica. Orientadora: Edilene Maria Queiroz Araujo; Coorientadora: Luama Araujo dos Santos. 2024. 97 f. Tese (Doutorado em Processos Interativos dos Órgãos e Sistemas) - Instituto de Ciências da Saúde, Universidade Federal da Bahia, Salvador, 2024.pt_BR
dc.identifier.urihttps://repositorio.ufba.br/handle/ri/41286-
dc.description.abstractIntroduction: Metabolic Syndrome (MetS) is a set of alterations with a strong inflammatory basis. It has a complex aetiology, interacting with environmental and genetic factors. Among the environmental factors, diet is an important treatment option, with various types of diet, and the genotype of the individuals can influence the response. Polymorphisms in genes that regulate the production of inflammatory cytokines participate in this interaction. In this sense, the general objective of this thesis was to investigate whether polymorphisms in genes related to inflammation influence the response to lactose-free dietary intervention in patients with metabolic syndrome. Methods: Two studies were carried out. Article 1 is a scoping review protocol, which was conducted according to the method recommended by the Joanna Briggs Institute (JBI) and the checklist proposed by the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews (PRISMA-ScR). A preliminary search strategy was developed for PubMed and adapted for the other databases. Two independent reviewers will perform the screening and data extraction. Article 2 is a randomized clinical trial with adults and elderly people of both sexes, with MetS. Sociodemographic, anthropometric, clinical and nutritional data were collected and randomized into three groups, according to the type of diet: diet 1, lactose-free; diet 2, lactose-free and low-calorie; diet 3, low-calorie diet only. The participants underwent blood collection for biochemical tests and DNA extraction, as well as for analysis of polymorphisms: rs1800629 (TNF); rs1800896 (IL-10); rs1800795 (IL-6); and rs1143634 (IL 1β). After two months of following the diet, biochemical tests were repeated, and anthropometric data was collected. According to genotype, the chi-square or Fisher’s exact tests was used for categorical variables, Kruskal-Wallis for medians between groups, and Wilcoxon for differences in cofactors after the intervention. Data were analyzed using the R statistical program and the adequacy of the genotype frequencies of polymorphisms. Results: In article 1, a scoping protocol was presented according to the JBI method; in article 2, the study population consisted mostly of females (85%), black skin color (50%), with a mean age of 57.6 (±8.81) years. Regarding the lactose-free and low-calorie diet group, a statistically significant association was found between rs1800896 (IL-10 -1082 G/A) and waist circumference (p=0.01) and BMI (p=0.002); in the lactose-free diet group, rs1143634 (IL-1β +3954 C/T) with blood glucose (p=0.07) and triglycerides (p=0.050); and, in the low-calorie diet group, rs1800629 (TNF-308 G/A) with HOMA-IR (p=0.003). Conclusion: The scoping review protocol will allow the investigation of the hypocaloric diet and its effect on MetS. The data from article 2 demonstrated that the inflammatory genetic profile can influence the response to the lactose-free diet.pt_BR
dc.languageporpt_BR
dc.publisherUniversidade Federal da Bahiapt_BR
dc.rightsAcesso Abertopt_BR
dc.subjectSíndrome metabólicapt_BR
dc.subjectPolimorfismo genéticopt_BR
dc.subjectDietoterapiapt_BR
dc.subjectnutrigenéticapt_BR
dc.subjectNutrigenômicapt_BR
dc.subject.otherMetabolic syndromept_BR
dc.subject.othergenetic polymorphismpt_BR
dc.subject.otherDiet therapypt_BR
dc.subject.othernutrigeneticspt_BR
dc.subject.otherNutrigenomicspt_BR
dc.titleInfluência de polimorfismos em genes relacionados à inflamação na resposta à intervenção dietoterápica sem lactose em pacientes com síndrome metabólicapt_BR
dc.title.alternativeInfluence of polymorphisms in genes related to inflammation on the response to lactose-free diet therapy intervention in patients with metabolic syndromept_BR
dc.typeTesept_BR
dc.publisher.programPrograma de Pós-Graduação em Processos Interativos dos Órgãos e Sistemas (PPGORGSISTEM) pt_BR
dc.publisher.initialsUFBApt_BR
dc.publisher.countryBrasilpt_BR
dc.subject.cnpqCNPQ::CIENCIAS DA SAUDE::NUTRICAO::ANALISE NUTRICIONAL DE POPULACAOpt_BR
dc.subject.cnpqCNPQ::CIENCIAS DA SAUDE::NUTRICAO::BIOQUIMICA DA NUTRICAOpt_BR
dc.contributor.advisor1Araújo, Edilene Maria Queiroz-
dc.contributor.advisor1IDhttps://orcid.org/0000-0003-0481-037Xpt_BR
dc.contributor.advisor1Latteshttp://lattes.cnpq.br/7394280781506129pt_BR
dc.contributor.advisor-co1Santos, Luama Araújo dos-
dc.contributor.advisor-co1Latteshttp://lattes.cnpq.br/9350244242655214pt_BR
dc.contributor.referee1Araújo, Edilene Maria Queiroz-
dc.contributor.referee1IDhttps://orcid.org/0000-0003-0481-037Xpt_BR
dc.contributor.referee1Latteshttp://lattes.cnpq.br/7394280781506129pt_BR
dc.contributor.referee2Almeida, Daniela Oliveira de-
dc.contributor.referee2Latteshttp://lattes.cnpq.br/4689047000860431pt_BR
dc.contributor.referee3Medeiros, Jairza Maria Barreto-
dc.contributor.referee3Latteshttp://lattes.cnpq.br/6674302443921098pt_BR
dc.contributor.referee4Machado, Maria Ester Pereira da Conceição-
dc.contributor.referee4Latteshttp://lattes.cnpq.br/1413009889910582pt_BR
dc.contributor.referee5Carvalho, Fernando Luís de Queiroz-
dc.contributor.referee5Latteshttp://lattes.cnpq.br/6679400555126839pt_BR
dc.creator.IDhttps://orcid.org/0000-0002-4128-1932pt_BR
dc.creator.Latteshttp://lattes.cnpq.br/0792597701257047pt_BR
dc.description.resumoIntrodução: A síndrome metabólica (SM) é um conjunto de alterações com forte base inflamatória. Possui etiologia complexa, com interação de fatores ambientais e genéticos. Dentre os fatores ambientais, a alimentação é uma importante opção de tratamento, com vários tipos de dieta, e a resposta pode ser influenciada pelo genótipo dos indivíduos. Polimorfismos em genes que regulam a produção de citocinas inflamatórias participam dessa interação. Nesse sentido, o objetivo geral desta tese foi investigar se polimorfismos em genes relacionados à inflamação influenciam na resposta à intervenção dietoterápica sem lactose, em pacientes com síndrome metabólica. Métodos: Foram realizados dois estudos. O artigo 1 constitui um protocolo de revisão de escopo, que foi conduzido de acordo com o método recomendado pelo Instituto Joanna Briggs (JBI) e pelo check list proposto pelo Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR). Foi desenvolvida uma estratégia de busca preliminar para o PubMed, que foi adaptada para as demais bases de dados. Dois revisores independentes realizarão a triagem e a extração dos dados. O artigo 2 é um ensaio clínico randomizado, com adultos e idosos, de ambos os sexos, com SM. Foram coletados dados sociodemográficos, antropométricos, clínicos e nutricionais e realizada uma randomização em três grupos, de acordo com o tipo de dieta: dieta 1, sem lactose; dieta 2, sem lactose e hipocalórica; dieta 3, dieta somente hipocalórica. Os participantes foram submetidos à coleta sanguínea para os exames bioquímicos e extração de DNA, bem como para análise dos polimorfismos: rs1800629 (TNF); rs1800896 (IL-10); rs1800795 (IL-6); e rs1143634 (IL-1β). Após seguimento de dois meses da dieta, foram repetidos os exames bioquímicos e coletados novamente os dados antropométricos. Foram utilizados os testes qui-quadrado ou exato de Fisher para as variáveis categóricas, Kruskal-Wallis para as medianas entre os grupos, e Wilcoxon para diferença nos cofatores após a intervenção, de acordo com o genótipo. Os dados foram analisados pelo programa estatístico R, bem como a adequação das frequências genotípicas dos polimorfismos. Resultados: No artigo 1, foi apresentado um protocolo de escopo de acordo com o método JBI; no artigo 2, a população de estudo foi constituída, em sua maioria, do sexo feminino (85%), cor de pele preta (50%), com média de idade de 57,6 (±8,81) anos. Com relação ao grupo da dieta sem lactose e hipocalórica, foi encontrada associação estatisticamente significativa do rs1800896 (IL-10 -1082 G/A) com a circunferência da cintura (p=0,01) e com o IMC (p = 0,002); no grupo de dieta sem lactose, do rs1143634 (IL 1β + 3954C/T) com a glicemia (p=0,07) e triglicerídeos (p = 0,05); e, no grupo de dieta hipocalórica, o rs1800629 (TNF-308 G/A) com o HOMA-IR (p= 0,003). Conclusão: O protocolo da revisão de escopo possibilitará investigar a dieta hipocalórica e seus efeitos na SM. Já os dados do artigo 2 demonstraram que o perfil genético inflamatório pode influenciar na resposta à dieta sem lactose.pt_BR
dc.publisher.departmentInstituto de Ciências da Saúde - ICSpt_BR
dc.relation.referencesAGODI, A. et al. Association of Dietary Patterns with Metabolic Syndrome: results from the Kardiovize Brno 2030 Study. Nutrients, v. 10, n. 7, p. 898, 13 July 2018. DOI: 10.3390/nu10070898. AHMED, B.; SULTANA, R.; GREENE, M. W. Adipose tissue and insulin resistance in obese. Biomedicine e Pharmacotherapy, New York, v. 137, p. 111315, 2021. DOI: 10.1016/j.biopha.2021.111315. ALBERTI, K.G.; ZIMMET, P.; SHAW, J. Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabetic Medicine, New York, v.23, n. 5, p. 469-480, 2006. DOI: 10.1111/j.1464-5491.2006.01858.x. ALMASSABI, R. F. et al. Differential expression of serum proinflammatory cytokine TNF-α and genetic determinants of TNF-α, CYP2C19*17, miR-423 genes and their effect on coronary artery disease predisposition and progression. Life (Basel), v. 13, n. 11, p. 2142, 2023. DOI: 10.3390/life13112142. ALHARBI, O.; EL-SOHEMY, A. Lactose Intolerance (LCT-13910C>T) Genotype is Associated with Plasma 25-Hydroxyvitamin D Concentrations in Caucasians: A Mendelian Randomization Study. The Journal of Nutrition, Estados Unidos, v. 147, n. 6, p. 1063-1069, 2017. DOI: 10.3945/jn.116.246108. AMBROSELLI, D. et al. New Advances in Metabolic Syndrome, from Prevention to Treatment: The Role of Diet and Food. Nutrients, Suiça,v. 15, n. 3, p. 640, 2023. DOI: 10.3390/nu15030640. APOVIAN, C. M. et al. Adipose macrophage infiltration is associated with insulin resistance and vascular endotelial dysfunction in obese subjects. Arteriosclerosis, Thrombosis, and Vascular Biology, Baltimore v. 28, n. 9, p. 1654-1659, 2008. DOI: 10.1161/ATVBAHA.108.170316. ARAUJO, E. M. Q. Intervenção dietoterápica na síndrome metabólica e sua associação com o perfil genético da intolerância à lactose. 2016. Tese (Doutorado em Biotecnologia) - Universidade Estadual de Feira de Santana – UEFS, Feira de Santana, 2016. ARAUJO, E. M. et al. Genetic and oral tests for the diagnosis of lactose intolerance in mixed ancestry Brazilians with metabolic syndrome. Lifestyle Genomics, [s.l], v. 12, n. 1-6, p.1-9, 2019. DOI: 10.1159/000501690 AYELIGN, B. et al. Association of IL-10 (-1082 A/G) and IL-6 (-174 G/C) gene polymorphism with type 2 diabetes mellitus in Ethiopia population. BMC Endocrine Disorders, London, v. 21, n. 1, p. 70, 15 abr. 2021. DOI: 10.1186/s12902-021-00738-1. BAYLESS, T. M.; BROWN, E.; PAIGE, D. M. Lactase Non-persistence and Lactose Intolerance. Current Gastroenterology Reports, Estados Unidos, v. 19, n. 5, p. 23, 2017. DOI: 10.1007/s11894-017-0558-9. BOSCH-SIERRA, N. et al. Effect of a Very Low-Calorie Diet on Oxidative Stress, Inflammatory and Metabolomic Profile in Metabolically Healthy and Unhealthy Obese Subjects. Antioxidants, Basel, v. 13, n. 3, p. 302, 29 Feb. 2024. DOI: https://doi.org/10.3390/antiox13030302 BOVOLINI, A. et al. Metabolic syndrome pathophysiology and predisponing factors. International Journal Sports Medicine, Sttufgart, v. 42, n. 3, p. 199-214, Oct. 2021. DOI: 10.1055/a-1263-0898. CARABA, A. et al. Anti TNF-alpha Treatment Improves Microvascular Endothelial Dysfunction in Rheumatoid Arthritis Patients. International Journal of Molecular Sciences, Basel, v. 25, n. 18, p. 9925, Sep. 2024. DOI: 10.3390/ijms25189925. CASTRO-BARQUERO, S. et al. Dietary Strategies for Metabolic Syndrome: A comprehensive Review. Nutrients, Suiça, v. 12, n. 10, p. 2983, Sep. 2020. DOI: 10.3390/nu12102983. CATANZARO, R.; SCIUTO, M.; MAROTTA, F. Lactose intolerance: an update on its pathogenesis, diagnosis, and treatment. Nutrition Research, New York, v. 89, p.23-34, 2021. DOI: 10.1016/j.nutres.2021.02.003. CHIKOTI, S. et al. Cytokine gene variants of TNF-α and IL-10 in the propensity of type 2 diabetes in south Indian population. Journal Diabetes and its Complications, New York, v. 36, n. 10, p.108304, out. 2022. DOI: 10.1016/j.jdiacomp.2022.108304. CREMONINI, A. C. P. et al. Metabolic Syndrome and Associated Factors in Farmers in Southeastern Brazil: A Cross-Sectional Study. International Journal of Environmental Research and Public Health, Basel, v. 20, n. 14, p. 6328, 2023. doi: 10.3390/ijerph20146328. COMERFORD, K.B.; PASIN, G. Gene-dairy food interactions and health outcomes: a review of nutrigenetic studies. Nutrients, Suiça, v. 9, n. 7, p. 710, 6 July 2017. DOI: 10.3390/nu9070710. DAYI, T.; OZGOREN, M. Effects of the Mediterranean diet on the components of metabolic syndrome. Journal of Preventive Medicine and Hygiene, Italy, v. 63, 2 supl. 3, p. E56-E64, 2022. DOI: 10.15167/2421-4248/jpmh2022.63.2S3.2747. DINIZ, M. F. H. S. et al. Homeostasis model assessment of insulin resistance (HOMA-IR) and metabolic syndrome at baseline of a multicentric Brazilian cohort: ELSA-Brasil study. Cad Saúde Publica, Rio de janeiro, v. 36, n. 8, p. e00072120, 2020. DOI: https://doi.org/10.1590/0102-311X00072120. DIRETRIZES DA SOCIEDADE BRASILEIRA DE DIABETES. SOCIEDADE BRASILEIRA DE DIABETES. Classificação etiológica do diabetes mellitus – Métodos e critérios para o diagnóstico do diabetes mellitus. Diretrizes da Sociedade Brasileira de Diabetes, São Paulo, p.18-23, 2019-2020. DUTRA, W. O. et al. Implications of cytokine gene polymorphisms on the orchestration of the immune response: Lessons learned from oral diseases. Cytokine & Growth Factor Reviews, Oxford, v. 20, n. 3, p. 223-232, 2009. DOI: 10.1016/j.cytogfr.2009.05.005. FACIONI, M. S. et al. Nutritional management of lactose intolerance: the importance of diet and food labelling. Journal Translacional Medicine, London, v. 18, p. 260, 2020. DOI: 10.1186/s12967-020-02429-2. FAHED, G. et al. Metabolic Syndrome: Updates on Pathophysiology and Management in 2021. International Journal Molecular Sciences, Basel, v. 23, n. 2, p. 786, 2022. DOI: 10.3390/ijms23020786. FILIPPOU, C. D. et al. Dietary Approaches to Stop Hypertension (DASH) Diet and Blood Pressure Reduction in Adults with and without Hypertension: A systematic Review and Meta Analysis of Randomized Controlled Trials. Advances in Nutrition, Estados Unidos, v. 11, n. 5, p. 1150-1160, 2020. DOI: 10.1093/advances/nmaa041. FRANGAZO, M. et al. Genes and diet in the Prevention of Chronic Diseases in Future Generations. International Journal of Molecular Sciences, Basel, v. 21, n. 7, p. 2633, 2020. DOI: 10.3390/ijms21072633. FREITAS, R. de S. et al. IL-10 and IL-1β serum levels, genetic variants, and metabolic syndrome: insights into older adults’ clinical characteristics. Nutrients, Suiça, v. 16, n.8, p. 1241, 2024. DOI: 10.3390/nu16081241. FRIEDRICH, D. C. et al. The lactase persistence genotype is a prospective factor for the metabolic syndrome. Genetics Molecular Biology, São Paulo, v. 37, n. 4, p. 611-615, 2014. DOI: https://doi.org/10.1590/S1415-47572014005000012. GHAREEB, D. et al. Association of TNF-α-308 G>A (rs1800629) polymorphism with susceptibility of metabolic syndrome. Journal Diabetes e Metabolic Disorder, Belgium, v. 20, n.1, p.209-215, 2021. DOI: 10.1007/s40200-021-00732-3. GODOS, J. et al. Adherence to the Mediterranean diet is inversely associated with metabolic syndrome occurrence: a meta-analysis of observational studies. International Journal of Food Sciences and Nutrition, London, v. 68, n. 2, p. 138–148, 2017. DOI: 10.1080/09637486.2016.1221900. GUTIÉRREZ-ESPARZA, G. et al. Sleep Quality, Nutrient Intake, and Social Development Index Predict Metabolic Syndrome in the Tlalpan 2020 Cohort: A Machine Learning and Synthetic Data Study. Nutrients, Suiça, v. 16, n. 5, p. 612, 2024. DOI: 10.3390/nu16050612. GUEST, N. S. et al. Sport Nutrigenomics: Personalized Nutrition for Athletic Performance. Frontiers in nutrition, Austrália, v. 6, p. 8, 19 fev. 2019. DOI: 10.3389/fnut.2019.00008. JAMALI, Z. et al. Metabolic syndrome: a population-based study of prevalence and risk factors. Scientific reports, London, v. 14, n. 1, p. 3987, 17 fev. 2024. DOI: 10.1038/s41598024-54367-4. JHA, B. K. et al. Progress in Understanding Metabolic and Knowledge of its Complex Pathophysiology. Diabetology, Suiça, v. 4, n.2, p. 134-159, 2023. DOI: https://doi.org/10.3390/diabetology4020015 JOFFE, Y. T. et al. Interleukin-6 gene polymorphisms, dietary fat intake, obesity and serum lipid concentrations in black and white South African women. Nutrients, Suiça, v. 6, n. 6, p. 2436-2465, 2014. DOI: 10.3390/nu6062436. KAHLEOVA, H. et al. Dietary Patterns and Cardiometabolic Outcomes in Diabetes: A Summary of Systematic Reviews and Meta-Analyses. Nutrients, Suiça, v. 11, n. 9, p. 2209, 2019. DOI: 10.3390/nu11092209. KAWAI, T.; AUTIERI, M. V.; SCALIA, R. Adipose tissue inflammation and metabolic dysfunction in obesity. American Journal of physiology. Cell physiology, Estados Unidos, v. 320, n. 3, p. C375-C391, 23 dez. 2020. DOI: 10.1152/ajpcell.00379.2020. KOUVARI, M. et al. Metabolic Syndrome, Cognitive Impairment and the Role of Diet: A Narrative Review. Nutrients, Suiça, v. 14, n. 2, p. 333, 2022. DOI: 10.3390/nu14020333. LEITE, B.F.; JAMAR, G.; CARANTI, D. A. Efeito dos ácidos graxos na Síndrome Metabólica: uma revisão de literatura. Journal Brazilian Socity Food Nutrition, São Paulo, v. 39, n. 1, p. 113-129, 2014. LEONSKA-DUNIEC, A. et al. Association of the TNF-α-308G/A polymorphism with lipid profile changes in response to aerobic training program. Biology of Sport, Poland, v. 36, n. 3, p. 291-296, 2019. DOI: 10.5114/biolsport.2019.85456. LEVSTEK, T. et al. The influence of treatment with PCSK9 inhibitors and variants in the CRP (rs1800947), TNF (rs1800629), and IL6 (rs1800795) genes on the corresponding inflammatory markers in patients with very high lipoprotein(a) levels. Journal of Cardiovascular Development and Disease, Switzerland, v. 9, n. 5, p. 127, 2022. DOI: 10.3390/jcdd9050127. LIMA, R. C. de.; BRANDÃO, N. A.; SANTOS, L. de F. dos. Estratégias Nutricionais para o tratamento da síndrome metabólica. In: ARAÚJO, E. M. Q. (org.). A Síndrome Metabólica e suas implicações clínicas. Salvador, Ba: Eduneb, 2018. p. 295-332 LIU, Y. et al. Impacts of pro-inflammatory cytokines variant on cardiometabolic profile and premature coronary artery disease: a systematic review and meta-analysis. Journal of Cellular and Molecular Medicine, Irlanda, v. 28, n. 8, p. e18311, 2024. DOI: 10.1111/jcmm.18311. LUOTOLA, K. et al. Association of Variation in the Interleukin-1 Gene Family with Diabetes and Glucose Homeostasis. The Journal of Clinical Endocrinology & Metabolism, New York, v. 94, n. 11, p. 4575-4583, 2009. DOI: 10.1210/jc.2009-0666. MACULEWICZ, E. et al. The interactions between interleukin-1 family genes: IL1A, 1L1β, IL1RN, and obesity parameters. BMC Genomics, London, v. 23, n. 1, p. 112, Feb. 2022. DOI: 10.1186/s12864-021-08258-x. MADESHIYA, A. K. et al. Association of IL-10 gene (-1082 A>G, -819 C>T and -592 C>A) polymorphism and its serum level with metabolic syndrome of north Indian subjects. Journal of Genetics, India, v. 96, n. 1, p. 53-64, 2017. MATTAR, R.; MAZO, D. F. de C. Intolerância à lactose: mudança de paradigmas com a biologia molecular. Revista da Associação Medica Brasileira, São Paulo, v. 56, n. 2, p. 230 - 236, 2010. DOI: https://doi.org/10.1590/S0104-42302010000200025. MERTENS E, et al. Adherence to a healthy diet in relation to cardiovascular incidence and risk markers: evidence from the Caerphilly Prospective Study. European Journal of Nutrition, Germany, v. 57, n. 3, p. 1245-1258, 2018. DOI: 10.1007/s00394-017-1408-0. MINIHANE, A.M. et al. Low-grade inflammation, diet composition and health: current research evidence and its translation. British Journal of Nutrition, New York, v. 114, n. 7, p. 999-1012, 2015. DOI: 10.1017/S0007114515002093. MISSELWITZ, B. et al. Update on lactose malabsorption and intolerance: pathogenesis, diagnosis and clinical management. Gut, Reino Unido, v. 68, n. 11, p. 2080-2091, 2019. DOI: 10.1136/gutjnl-2019-318404. MONTEFUSCO, L. et al. Anti-inflammatory effects of diet and caloric restriction in metabolic syndrome. Journal of Endocrinological Investigation, Italy, v. 44, n. 11, p.2407 - 2415, 2021. DOI: 10.1007/s40618-021-01547-y. MILLER, A.S.; DYKES, D. D.; POLESKY, H. F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Research, London, v. 16, n. 3, p. 1215, 11 fev. 1988. DOI: 10.1093/nar/16.3.1215. MORENGA, L. A. T. et al. Comparison of high protein and high fiber weight-loss diets in women with risk factors for the metabolic syndrome: a randomized trial. Nutrition Journal, Estados Unidos, v. 10, p. 40, 28 Apr. 2011. DOI: 10.1186/1475-2891-10-40. MTHEMBU, S. X. H. et al. Impact of physical exercise and caloric restriction in patients with type 2 diabetes: Skeletal muscle insulin resistance and mitochondrial dysfunction as ideal therapeutic targets. Life Sciences, Amsterdam, v. 297, p. 120467, 15 May 2022. DOI: 10.1016/j.lfs.2022.120467. MULLINS, V. A. et al. Genomics in Personalized Nutrition: Can You “Eat for Your Genes”? Nutrients, Suiça, v. 12, n. 10, p. 3118, 2020. DOI: 10.3390/nu12103118. MURALIDHARAN, J. et al. Effect on gut microbiota of a 1-y lifestyle intervention with Mediterranean diet compared with energy-reduced Mediterranean diet and physical activity promotion: PREDIMED-Plus Study. The American Journal of Clinical Nutrition, Estados Unidos, v. 114, n. 3, p. 1148-1158, 1 set. 2021. DOI: 10.1093/ajcn/nqab150 NELSON, J. E. et al. Increased parenchymal damageand steatohepatitis in Caucasian nonalcoholic fatty liver disease patients with common IL1B and IL6 polymorphisms. Alimentary Pharmacology Therapeutics, England, v. 44, n. 11-12, p. 1253-1264, 2016. DOI: 10.1111/apt.13824. NORDE, M. M. et al. Influence of IL1B, IL6 and IL10 gene variants and plasma fatty acid interaction on metabolic syndrome risk in a cross-sectional population-based study. Clinical Nutrition, Philadelphia, v. 37, n. 2, p. 659-666, 2018. DOI: 10.1016/j.clnu.2017.02.009. OLIVEIRA, L. V. A. et al. Prevalence of the Metabolic Syndrome and its componentes in the Brazilian adult population. Ciên Saúde Colet, Rio de janeiro, v. 25, p.4269-4280, 2020. DOI: 10.1590/1413-812320202511.31202020. ORGANIZAÇÃO MUNDIAL DE SAÚDE (OMS). Physical status: the use and interpretation of anthropometry. Geneva: WHO, 1995. ORGANIZAÇÃO PAN-AMERICANA DA SAÚDE. ORGANIZAÇÃO MUNDIAL DA SAÚDE. Plano estratégico 2003-2007 da Repartição Sanitária Pan-Americana. 26ª Conferência Sanitária Pan-Americana - 54ª Sessão do Comitê Regional. Washington DC: Organização Pan-Americana da Saúde; Organização Mundial da Saúde, 2002. 51p. PAGE, M. J. et al. The PRISMA 2020 statement: na updated guideline for reporting systematic reviews. British Medical Association, Inglaterra, v. 372, p. n71, 2021. DOI: 10.1136/bmj.n71. PALEY, C.A; JOHNSON, M. I. Abdominal obesity and metabolic syndrome: exercise as medicine? BMC Sports Science, Medicine and Rehabilitation, London, v. 10, p.7, 2018. DOI: 10.1186/s13102-018-0097-1 PHILLIPS, C. M. et al. Additive effect of Polymorphisms in the IL-6, LTA, and TNFα genes and plasma fatty acid level modulate risk for the metabolic syndrome its components. The Journal of Clinical Endocrinology e Metabolism, New York, v. 95, n. 3, p. 1386-1394, 2010. DOI: 10.1210/jc.2009-1081. POPKO, K. et al. Proinflammatory cytokines Il-6 and TNF-α and the development of inflammation in obese subjects. European Journal of Medical Research, Munich, v. 15, supl. 2, p. 120-122, 2010. DOI: 10.1186/2047-783x-15-s2-120. PÉREZ-BELTRÁN, Y. E. et al. A Nutrigenetic Strategy for reducing blood lipids and Low Grade Inflammation in Adults with Obesity and Overweight. Nutrients, Suiça, v. 15, n. 20, p. 4324, 2023. DOI: 10.3390/nu15204324. RANA, B. K. et al. The IL6 gene promoter SNP and plasma IL-6 in response to diet intervention. Nutrients, Suiça, v. 9, n. 6, p. 552, 2017. DOI: 10.3390/nu9060552. ROCHLANI, Y. et al. Metabolic syndrome: pathophysiology, management, and modulation by natural compounds. Therapeutic Advances in Cardiovascular Disease, Thousand Oaks, v. 11, n. 8, p.215-225, 2017. DOI: 10.1177/1753944717711379. SAKLAYEN, M. G. The Global Epidemic of the Metabolic Syndrome. Current Hypertension Reports, [s.l.], v. 20, n. 2, p. 12, 2018. DOI: 10.1007/s11906-018-0812-z. SOCIEDADE BRASILEIRA DE CARDIOLOGIA. I Diretriz Brasileira de Diagnóstico e Tratamento da Síndrome Metabólica. Arquivos Brasileiros de Cardiologia, Rio de Janeiro, v. 84, supl I, 2005. DOI: https://doi.org/10.1590/S0066-782X2005000700001. STECKHAN, N. et al. Effects of diferente dietary approaches on inflammatory markers in patients with metabolic syndrome: a systematic review and meta-analysis. Nutrition, Suiça, v. 32, n. 3, p. 338-348, 2016. DOI: 10.1016/j.nut.2015.09.010. SZKUP, M. et al. The influence of the TNFα rs1800629 polymorphism on some inflammatory biomarkers in 45-60-year-old women with metabolic syndrome. Aging (Albany NY), New York, v. 10, n. 10, p. 2935-2943, Oct. 2018. DOI: 10.18632/aging.101600. THOR, S.M.; YAU, J.W.; RAMADAS, A. Nutritional and lifestyle intervention strategies for metabolic in Southeast Asia: a scoping review of recent evidence. PLoS One. California, v. 16, n. 9, p. e0257433, 14 set 2021. DOI: 10.1371/journal.pone.0257433. TODENDI, P. F. et al. Low-grade inflammation markers in children and adolescents: Influence of anthropometric characteristics and CRP and IL6 polymorphisms. Cytokine, Estados Unidos, v. 88, p. 177-183, 2016. DOI: 10.1016/j.cyto.2016.09.007. VAJDI, M.; FARHANGI, M.A.; NIKNIAZ, L. Diet-derived nutrient patterns and components of metabolic syndrome: a cross-sectional community-based study. BMC Endocrine Disorders, London, v. 20, p.69, 2020. DOI: 10.1186/s12902-020-0547-0. VIMALESWARAN, K.S. et al. Evidence for a causal association between milk intake and cardiometabolic disease outcomes using a two-sample Mendelian Randomization analysis in up to 1,904,220 individuals. International Journal of Obesity, London, v. 45, n. 8, p. 1751 - 1762, 2021. DOI: 10.1038/s41366-021-00841-2. ZHANG, J. M.; AN, J. Cytokines, Inflammation and Pain. International Anesthesiology Clinical, Philadelphia, v. 45, n. 2, p. 27-37, 2007. DOI: 10.1097/AIA.0b013e318034194e. ZINGONE, F. et al. Myths and Facts about Food Intolerance: A Narrative Review. Nutrients, Suiça, v. 15, n. 23, p. 4969, Nov. 2023. DOI: 10.3390/nu15234969.pt_BR
dc.type.degreeDoutoradopt_BR
Aparece nas coleções:Tese (PPGPIOS)

Arquivos associados a este item:
Arquivo Descrição TamanhoFormato 
Tese Najara Brandão.pdfTese de doutorado. Najara.1,59 MBAdobe PDFVisualizar/Abrir
Mostrar registro simples do item Visualizar estatísticas


Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.